Lista de obras -

Acute Liver Failure Associated With Pomalidomide Therapy for Multiple Myeloma

scientific article published on 26 May 2018

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

artículo científico publicado en 2019

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

artículo científico publicado en 2018

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma.

artículo científico publicado en 2014

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

artículo científico publicado en 2019

Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy

artículo científico publicado en 2015

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

artículo científico publicado en 2017

Cellular and vaccine immunotherapy for multiple myeloma.

artículo científico publicado en 2016

Cellular immunotherapy for plasma cell myeloma.

artículo científico

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

artículo científico publicado en 2015

Chimeric Antigen Receptor T Cells in Myeloma

artículo científico publicado en 2016

Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applications

scientific article published on 25 February 2019

Classifying ultra-high risk smoldering myeloma.

artículo científico publicado en 2014

Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer

artículo científico publicado en 2016

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

artículo científico publicado en 2015

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

artículo científico publicado en 2015

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient

scientific article published on 20 February 2019

Immunotherapy with chimeric antigen receptors for multiple myeloma

artículo científico publicado en 2014

Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer

artículo científico publicado en 2007

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation

artículo científico publicado en 2013

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

artículo científico publicado en 2016

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts

artículo científico publicado en 2016

Multitargeted CAR T-cell therapy in multiple myeloma

scientific article published on 01 August 2019

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

artículo científico publicado en 2015

Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.

artículo científico

Promoting professionalism through an online professional development portfolio: successes, joys, and frustrations.

artículo científico publicado en 2007

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

scientific article published on 12 June 2019

RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

scientific article published on 13 February 2019

Reflections on the role of the professionalism curriculum in medical school.

artículo científico publicado en 2007

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies

scientific article published on 01 August 2019

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

scientific article published on 01 October 2019

The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies

artículo científico publicado en 2016

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

artículo científico publicado en 2021

Trials and Tribulations with VH Replacement

artículo científico

Lista de obras de

Acute Liver Failure Associated With Pomalidomide Therapy for Multiple Myeloma

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma.

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

Cellular and vaccine immunotherapy for multiple myeloma.

Cellular immunotherapy for plasma cell myeloma.

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

Chimeric Antigen Receptor T Cells in Myeloma

Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applications

Classifying ultra-high risk smoldering myeloma.

Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient

Immunotherapy with chimeric antigen receptors for multiple myeloma

Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts

Multitargeted CAR T-cell therapy in multiple myeloma

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.

Promoting professionalism through an online professional development portfolio: successes, joys, and frustrations.

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

Reflections on the role of the professionalism curriculum in medical school.

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

Trials and Tribulations with VH Replacement